Center for Infectious Disease Epidemiologic Research, Mailman School of Public Health, Columbia University — New York, New York

Center for Infectious Disease Epidemiologic Research, Mailman School of Public Health, Columbia University is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Center for Infectious Disease Epidemiologic Research, Mailman School of Public Health, Columbia University has participated in 1 clinical trials.

Therapeutic areas: HIV Prevention.

Sponsors: CONRAD.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Center for Infectious Disease Epidemiologic Research, Mailman School of Public Health, Columbia University?

Center for Infectious Disease Epidemiologic Research, Mailman School of Public Health, Columbia University has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Center for Infectious Disease Epidemiologic Research, Mailman School of Public Health, Columbia University conducted?

Center for Infectious Disease Epidemiologic Research, Mailman School of Public Health, Columbia University has 1 clinical trials on record. Their work covers HIV Prevention.

Is Center for Infectious Disease Epidemiologic Research, Mailman School of Public Health, Columbia University accredited by Crixeo Health?

Center for Infectious Disease Epidemiologic Research, Mailman School of Public Health, Columbia University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Center for Infectious Disease Epidemiologic Research, Mailman School of Public Health, Columbia University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.